मैट्रिक्स
 
 
अल्प लेबोरेटरीज > कंपनी इतिहास > Pharmaceuticals > कंपनी इतिहास का अल्प लेबोरेटरीज - बीएसई: 532878, NSE: ALPA

अल्प लेबोरेटरीज

बीएसई: 532878  |  NSE: ALPA  |  ISIN: INE385I01010  |  Pharmaceuticals

कंपनी इतिहास - अल्प लेबोरेटरीज
Mr. Purushottam R. Patel, Mr. M.S. Chawla and Mr. Pravin C. Shah, 
 partners of M/s Alpa Laboratories, which was formed in the year 
 1967, incorporated a private limited company in the name of Alpa 
 Laboratories Private Limited on March 18, 1988 for manufacture 
 of pharmaceutical formulations. In the year 1998, Alpa Laboratories 
 Private Limited was converted into a public limited company with 
 effect from September 3, 1998 with the name of Alpa Laboratories 
 Limited.
 
 In the year 1997, we initiated setting of a new manufacturing unit 
 at 33/2, Pigdamber, A.B. Road, Rau, District Indore, Madhya Pradesh.
 
 The unit commenced commercial production in the year 1999 of 
 all types of formulations viz. Injectables (Vials/Ampoules both
 liquid 
 and Dry), tablets, capsules, eye/ear drops, ointment and creams.
 
 We manufacture a range of products such as ethical drugs, generic 
 drugs, over the counter drugs (OTC) and veterinary products in 
 various dosage forms and market them under the trade mark Alpa
 which is a registered trademark in the name of Alpa Labs (India) 
 Limited, a promoter group company. We also manufacture 
 formulations for a number of other pharmaceutical companies of
 national and international repute such as Cipla, Zydus Cadila, 
 Lupin, Glenmark, Genom Biotech, Jenburkt, etc. (under their 
 own brands) located both in India and abroad in countries such 
 as Philippines, Iran, Iraq, Sierra Leon, Madagascar, Kenya, 
 Liberia, Puerto Rico, Haiti, Sudan, Ghana, Nigeria, Srilanka etc. 
 Further, we also undertake contract manufacturing of a large 
 variety of pharmaceuticals.
 
 We manufacture various dosage forms which include injectables 
 (vials / ampoules both liquid and dry), tablets, capsules, eye / ear
 
 drops, ointment and creams and dry syrups. We have an 
 established product-marketing network covering both metro and 
 mini metro cities, which enable us to reach our existing and 
 potential customers through our network of distributors and 
 dealers spread across the country. For the purpose of marketing 
 the various products, our Company's business has been 
 categorized as Branded Generic Division, Veterinary Division, 
 Exports Division and Contract Manufacturing Division.
 
 HISTORY AND MAJOR EVENTS
 
 1988        Incorporation of Alpa Laboratories Private Limited
 1997        Commenced setting up of manufacturing facility at 
                 Pigdamber, Indore
 1998        Conversion to Alpa Laboratories Limited, a public limited
 
                 company
 1999        Start of commercial production
  2001       WHO GMP Certification for its manufacturing facilities
                 Entered into an agreement for Contract manufacturing
 
                 at its newly constructed facility, with Plethico 
                 Pharmaceuticals Ltd., a Pharmaceutical company, for
                 manufacturing its various range of products.
                 The manufacturing facilities at Pigdamber were
 certified 
                as WHO GMP compliant by SGS-ICS Belgium for the 
                period 2001-02.
 2003       Certified ISO 9001: 2000*
                The manufacturing facility at Pigdamber was approved
 by 
                the Director General of Quality Assurance (DGQA),
 India 
                thereby opening its doors for participating in Tenders
 for 
               supplies to defence institutions**
               Started export of its Veterinary products and
 registered its 7 
               veterinary products in Sudan
 2006      Started participation in international tenders for export
 in 
               addition to domestic marketing abroad and won a major 
               tender from CMS, Sudan. Launched Veterinary Division 
               with a new face and ethical promotion of its Veterinary
 
               products launched in 5 states in the year 2006.
               Launched Ethical division for its human products
             * Expired on May 14, 2006
             ** Expired on January 22, 2006. This certificate is not 
              required now as our revenue have crossed Rs 2000.00 
              lakhs as per DGQA norms.
 
 2007
 
 -Alpa Laboratories ties up with Vhermann Pharmaceutical Inc,
 Philippines for distribution of its products.
 
 2010
 
 - The Company has recommended dividend of 10%.
 
 2014
 
 - Ms. Monali Patel, Member of The Institute of Company Secretaries of
 India (ICSI) has been appointed as the Company Secretary and
 Compliance Officer.
 
 - Alpa Laboratories has sold its Unit-II (Undertaking) situated at
 Sector III, Pithampur, Dhar (M.P.) as a going concern on a slump sale
 basis to Ipca Laboratories Limited.
 
 2015
 -Alpa Laboratories Ltd has formed a wholly owned subsidiary under the
 name and style of Norfolk Mercantile Private Ltd. 
 
 
 
 
 
 
 
स्रोत: रेलीगरे टेचनोवा

न्यूज़ फ़्लैश

  • BREAKING NEWS LOWER : महाराष्ट्र चुनाव पर CM फड़णवीस का बड़ा बयान
  • BREAKING NEWS LOWER : महाराष्ट्र में हमारी धमाकेदार वापसी होगी
  • BREAKING NEWS LOWER : HC चुनाव का समय देख कर कार्रवाई नहीं करता
  • BREAKING NEWS LOWER : पवार फैमली पर कानून के दायरे में ED की जांच
  • BREAKING NEWS LOWER : शिवसेना के CM पद के दावे पर फड़णवीस का बयान
  • BREAKING NEWS LOWER : हर किसी को सपने देखने का अधिकार है
  • BREAKING NEWS LOWER : 5 सालों में किसान आत्महत्या में कमी आई
  • BREAKING NEWS LOWER : किसान आत्महत्या शरद पवार की नाकामी का नतीजा
  • BREAKING NEWS LOWER : अगले 5 सालों तक महाराष्ट्र में ही काम करूंगा
  • BREAKING NEWS LOWER : PMC बैंक मामले में लोग बहुत प्रताड़ित हुए

अभी देखें

OUR WINNING PICKS

DID YOU INVEST?

INTRADAY PICKS!

(August 06, 2018)

AT (Rs)



GAIN (Rs)

ALL TIME WINNERS

RECO PRICE

PEAK PRICE

OUR PACKAGES

Super Combo

Powerful mix of both trader and investor packs with timely expert advice.

Technical

Designed especially for traders looking to tap the profit opportunities of volatile markets.

Fundamental

For all investors looking to unearth stocks that are poised to move.